CN111233717B - Method for separating useful components in taurine crystallization mother liquor - Google Patents
Method for separating useful components in taurine crystallization mother liquor Download PDFInfo
- Publication number
- CN111233717B CN111233717B CN202010080277.5A CN202010080277A CN111233717B CN 111233717 B CN111233717 B CN 111233717B CN 202010080277 A CN202010080277 A CN 202010080277A CN 111233717 B CN111233717 B CN 111233717B
- Authority
- CN
- China
- Prior art keywords
- taurine
- mother liquor
- useful components
- crystallization
- isethionic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 title claims abstract description 194
- 229960003080 taurine Drugs 0.000 title claims abstract description 94
- 238000002425 crystallisation Methods 0.000 title claims abstract description 55
- 230000008025 crystallization Effects 0.000 title claims abstract description 55
- 239000012452 mother liquor Substances 0.000 title claims abstract description 37
- 238000000034 method Methods 0.000 title claims abstract description 28
- SUMDYPCJJOFFON-UHFFFAOYSA-N isethionic acid Chemical compound OCCS(O)(=O)=O SUMDYPCJJOFFON-UHFFFAOYSA-N 0.000 claims abstract description 84
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 38
- 229940045996 isethionic acid Drugs 0.000 claims abstract description 36
- 229940045998 sodium isethionate Drugs 0.000 claims abstract description 26
- LADXKQRVAFSPTR-UHFFFAOYSA-M sodium;2-hydroxyethanesulfonate Chemical compound [Na+].OCCS([O-])(=O)=O LADXKQRVAFSPTR-UHFFFAOYSA-M 0.000 claims abstract description 26
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims abstract description 21
- 238000001816 cooling Methods 0.000 claims abstract description 13
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims abstract description 12
- 230000007062 hydrolysis Effects 0.000 claims abstract description 11
- 238000006460 hydrolysis reaction Methods 0.000 claims abstract description 11
- 230000020477 pH reduction Effects 0.000 claims abstract description 8
- 238000001556 precipitation Methods 0.000 claims abstract description 8
- WDIHJSXYQDMJHN-UHFFFAOYSA-L barium chloride Chemical compound [Cl-].[Cl-].[Ba+2] WDIHJSXYQDMJHN-UHFFFAOYSA-L 0.000 claims abstract description 6
- 229910001626 barium chloride Inorganic materials 0.000 claims abstract description 6
- 238000006386 neutralization reaction Methods 0.000 claims abstract description 6
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 claims abstract description 3
- 239000000706 filtrate Substances 0.000 claims description 32
- 238000003756 stirring Methods 0.000 claims description 29
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 26
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 24
- 239000000047 product Substances 0.000 claims description 24
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 24
- TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 claims description 20
- 238000006243 chemical reaction Methods 0.000 claims description 18
- 230000032050 esterification Effects 0.000 claims description 17
- 238000005886 esterification reaction Methods 0.000 claims description 17
- 238000000926 separation method Methods 0.000 claims description 16
- 239000011780 sodium chloride Substances 0.000 claims description 13
- 238000001914 filtration Methods 0.000 claims description 10
- 239000002202 Polyethylene glycol Substances 0.000 claims description 8
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 claims description 8
- -1 and at the same time Chemical compound 0.000 claims description 8
- 229920001223 polyethylene glycol Polymers 0.000 claims description 8
- 229910052938 sodium sulfate Inorganic materials 0.000 claims description 8
- 235000011152 sodium sulphate Nutrition 0.000 claims description 8
- 239000013078 crystal Substances 0.000 claims description 5
- 239000007787 solid Substances 0.000 claims description 5
- 239000007790 solid phase Substances 0.000 claims description 5
- 230000035484 reaction time Effects 0.000 claims description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 3
- 230000000694 effects Effects 0.000 claims description 3
- 239000011734 sodium Substances 0.000 claims description 3
- 229910052708 sodium Inorganic materials 0.000 claims description 3
- KQFAFFYKLIBKDE-UHFFFAOYSA-M sodium;ethanesulfonate Chemical compound [Na+].CCS([O-])(=O)=O KQFAFFYKLIBKDE-UHFFFAOYSA-M 0.000 claims description 3
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 claims description 2
- 241000283690 Bos taurus Species 0.000 claims description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 claims description 2
- 238000001704 evaporation Methods 0.000 claims 1
- 230000008020 evaporation Effects 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 abstract description 8
- 239000002994 raw material Substances 0.000 abstract description 6
- 239000002699 waste material Substances 0.000 abstract description 6
- 239000007788 liquid Substances 0.000 abstract description 5
- 238000011084 recovery Methods 0.000 abstract description 3
- 238000003912 environmental pollution Methods 0.000 abstract description 2
- 230000003321 amplification Effects 0.000 abstract 1
- 238000003199 nucleic acid amplification method Methods 0.000 abstract 1
- 238000002474 experimental method Methods 0.000 description 4
- 239000006227 byproduct Substances 0.000 description 3
- 238000009776 industrial production Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- PXMFTSPIHCAKHZ-UHFFFAOYSA-N azanium;2-aminoethanesulfonate Chemical compound [NH4+].NCCS([O-])(=O)=O PXMFTSPIHCAKHZ-UHFFFAOYSA-N 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000013341 scale-up Methods 0.000 description 2
- GEHJYWRUCIMESM-UHFFFAOYSA-L sodium sulfite Chemical compound [Na+].[Na+].[O-]S([O-])=O GEHJYWRUCIMESM-UHFFFAOYSA-L 0.000 description 2
- GWLWWNLFFNJPDP-UHFFFAOYSA-M sodium;2-aminoethanesulfonate Chemical compound [Na+].NCCS([O-])(=O)=O GWLWWNLFFNJPDP-UHFFFAOYSA-M 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 238000007259 addition reaction Methods 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 230000001760 anti-analgesic effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 238000009388 chemical precipitation Methods 0.000 description 1
- 238000012824 chemical production Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940093476 ethylene glycol Drugs 0.000 description 1
- 239000006081 fluorescent whitening agent Substances 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 230000020958 lipid digestion Effects 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 230000009965 odorless effect Effects 0.000 description 1
- 239000006174 pH buffer Substances 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 235000010265 sodium sulphite Nutrition 0.000 description 1
- PANBYUAFMMOFOV-UHFFFAOYSA-N sodium;sulfuric acid Chemical compound [Na].OS(O)(=O)=O PANBYUAFMMOFOV-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
- C07C303/42—Separation; Purification; Stabilisation; Use of additives
- C07C303/44—Separation; Purification
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
技术领域technical field
本发明涉及化工分离技术领域,尤其涉及一种分离牛磺酸结晶母液中有用成分的方法。The invention relates to the technical field of chemical separation, in particular to a method for separating useful components in taurine crystallization mother liquor.
背景技术Background technique
牛磺酸的化学名称为 2-氨乙基磺酸,分子式为 HO3S-CH2-CH2-NH2,化学名称为β-氨乙基磺酸或2-氨乙基磺酸,相对分子质量为125.15。工业生产使用的牛磺酸为白色晶状粉体,熔点328℃,无毒、无臭、味微酸,牛磺酸是调节机体正常生理活动的活性物质,具有消炎、镇痛、维持机体渗透压平衡、调节细胞钙平衡、调节脂类消化与吸收、增加心脏收缩能力、提高机体免疫能力等生物学功能,牛磺酸可广泛用于医药、荧光增白剂、食品添加剂、生化试剂、湿润剂及pH 缓冲剂等。The chemical name of taurine is 2-aminoethylsulfonic acid, the molecular formula is HO 3 S-CH 2 -CH 2 -NH 2 , the chemical name is β-aminoethyl sulfonic acid or 2-aminoethyl sulfonic acid, relative to The molecular mass is 125.15. The taurine used in industrial production is a white crystalline powder with a melting point of 328°C, non-toxic, odorless, and slightly sour in taste. Taurine is an active substance that regulates the normal physiological activities of the body. It has anti-inflammatory, analgesic, and maintains body penetration. Pressure balance, regulate cell calcium balance, regulate lipid digestion and absorption, increase cardiac contractility, improve body immunity and other biological functions, taurine can be widely used in medicine, fluorescent whitening agent, food additives, biochemical reagents, moisturizing agents and pH buffers.
工业生产中,采用环氧乙烷法制备牛磺酸分三步反应:第一步是环氧乙烷与亚硫酸钠的加成反应,生成羟乙基磺酸钠,但也生成有副产物乙二醇、聚乙二醇;第二步是羟乙基磺酸钠发生氨化反应,生成氨乙基磺酸钠,这步反应也会生成副产物氨乙基磺酸氨,另外还有一部分羟乙基磺酸钠未反应完全;第三步是氨乙基磺酸钠与硫酸进行酸化反应生成氨乙基磺酸,即牛磺酸,在此有副产物硫酸钠生成。In industrial production, the preparation of taurine by the ethylene oxide method is divided into three steps: the first step is the addition reaction of ethylene oxide and sodium sulfite to generate sodium isethionate, but also generates a by-product ethylene di Alcohol, polyethylene glycol; the second step is the ammoniation reaction of sodium isethionate to generate sodium aminoethylsulfonate, this step reaction will also generate by-product aminoethylsulfonate ammonia, in addition to a part of hydroxyethyl sulfonate Sodium ethyl sulfonate is not completely reacted; the third step is that sodium aminoethyl sulfonate and sulfuric acid are acidified to generate aminoethyl sulfonic acid, namely taurine, and sodium sulfate is generated by by-product here.
上述三步反应完成后,再经蒸发结晶、离心分离后得到牛磺酸成品,结晶母液组成为:牛磺酸13%、羟乙基磺酸钠50%、乙二醇及聚乙二醇4%、硫酸钠2%以及极少量氨乙基磺酸氨,其中有用成分为牛磺酸和羟乙基磺酸钠,牛磺酸可作为成品出售,而羟乙基磺酸钠为用于氨化生产牛磺酸的原料,工业生产中结晶母液因含有较多杂质成分,难以回用,作为废液排放不仅浪费资源,而且污染环境。After the above-mentioned three-step reactions are completed, the taurine finished product is obtained after evaporative crystallization and centrifugal separation, and the crystallization mother liquor is composed of: 13% of taurine, 50% of sodium isethionate, ethylene glycol and polyethylene glycol 4 %, sodium sulfate 2% and a very small amount of ammonia aminoethylsulfonate, of which the useful components are taurine and sodium isethionate, taurine can be sold as a finished product, and sodium isethionate is used for ammonia. It is a raw material for chemical production of taurine. In industrial production, the crystallization mother liquor contains many impurity components and is difficult to reuse. Discharging it as a waste liquid not only wastes resources, but also pollutes the environment.
牛磺酸上述成分均易溶于水,常规化学沉淀、蒸发结晶、冷却结晶、膜分离、离子交换等方法均难以从牛磺酸结晶母液中分离出有效成分,因此,如何有效分离牛磺酸结晶母液中的有用成分牛磺酸和羟乙基磺酸钠,已成为工业制备牛磺酸亟需解决的问题。The above-mentioned components of taurine are all easily soluble in water, and methods such as conventional chemical precipitation, evaporative crystallization, cooling crystallization, membrane separation, and ion exchange are all difficult to isolate the active ingredient from the taurine crystallization mother liquor. Therefore, how to effectively separate taurine The useful components taurine and sodium isethionate in the crystallization mother liquor have become an urgent problem to be solved in the industrial preparation of taurine.
发明内容SUMMARY OF THE INVENTION
本发明所解决的技术问题在于提供一种分离牛磺酸结晶母液中有用成分的方法,该方法经沉淀、酸化、酯化、水解、蒸发结晶、冷却结晶等工艺,最终分离出牛磺酸和羟乙基磺酸钠,利用该方法不仅可有效回收牛磺酸结晶母液中的有用成分牛磺酸和羟乙基磺酸钠,且可以显著减少牛磺酸生产废液排放可能带来的环境污染,具有生产成本低、回收率高,易于工业放大的优点。The technical problem solved by the present invention is to provide a method for separating useful components in the taurine crystallization mother liquor. The method undergoes processes such as precipitation, acidification, esterification, hydrolysis, evaporative crystallization, cooling crystallization and the like, and finally separates taurine and Sodium isethionate, using this method can not only effectively recover the useful components taurine and sodium isethionate in the taurine crystallization mother liquor, but also can significantly reduce the possible environment caused by the discharge of taurine production waste liquid It has the advantages of low production cost, high recovery rate and easy industrial scale-up.
本发明所解决的技术问题采用以下技术方案来实现:The technical problem solved by the present invention adopts the following technical solutions to realize:
一种分离牛磺酸结晶母液中有用成分的方法,具体步骤如下:A method for separating useful components in taurine crystallization mother liquor, the concrete steps are as follows:
(1)沉淀:在适量牛磺酸结晶母液中加入用于去除硫酸盐的氯化钡,搅拌,使硫酸钡充分析出,过滤分离硫酸钡,得一级滤液;(1) Precipitation: add barium chloride for removing sulfate to an appropriate amount of taurine crystal mother liquor, stir to fully separate out barium sulfate, filter and separate barium sulfate to obtain a first-grade filtrate;
(2)酸化:在一级滤液中加入浓盐酸,升温至80℃温度条件下搅拌,促使羟乙基磺酸钠转化为羟乙基磺酸,同时会有氯化钠析出,过滤分离氯化钠,得二级滤液;(2) Acidification: Add concentrated hydrochloric acid to the primary filtrate, heat up to 80 °C and stir to promote the conversion of sodium isethionate into isethionic acid, and at the same time, sodium chloride will be precipitated, and the chloride is separated by filtration. Sodium to obtain secondary filtrate;
(3)酯化:在二级滤液中加入适量乙醇,于90℃温度条件下继续搅拌反应,溶液出现分层,分为水层和油层,水层含有乙醇、乙二醇、聚乙二醇及少量氯化钠和硫酸钠,分离水层后,油层含有酯化产物,包括牛磺酸酯和羟乙基磺酸酯;(3) Esterification: Add an appropriate amount of ethanol to the secondary filtrate, and continue to stir the reaction at 90 °C. The solution is layered and divided into an aqueous layer and an oil layer. The aqueous layer contains ethanol, ethylene glycol, and polyethylene glycol. and a small amount of sodium chloride and sodium sulfate, after separating the water layer, the oil layer contains esterification products, including taurine and isethionate;
(4)水解:在步骤(3)生成的油层中加入适量水,于80℃温度条件下继续搅拌反应得水解产物,通过加水搅拌促使牛磺酸酯和羟乙基磺酸酯分别转化为牛磺酸和羟乙基磺酸;(4) Hydrolysis: add an appropriate amount of water to the oil layer generated in step (3), continue to stir and react at 80 °C to obtain a hydrolyzed product, and promote the conversion of taurine and isethionate into cattle by adding water and stirring. Sulfonic acid and isethionic acid;
(5)蒸发结晶:对步骤(4)得到的水解产物进一步于95℃温度条件下蒸发结晶,析出羟乙基磺酸,过滤分离羟乙基磺酸后,得三级滤液;(5) Evaporative crystallization: the hydrolyzed product obtained in step (4) is further evaporated and crystallized at a temperature of 95 °C to separate out isethionic acid, and after filtration and separation of isethionic acid, a tertiary filtrate is obtained;
(6)冷却结晶:将步骤(5)得到的三级滤液于5℃温度条件下冷却结晶,直至牛磺酸充分析出,过滤分离固相产物,得到牛磺酸;(6) Crystallization by cooling: the tertiary filtrate obtained in step (5) was crystallized by cooling at a temperature of 5°C until taurine was fully separated out, and the solid-phase product was filtered and separated to obtain taurine;
(7)羟乙基磺酸中和:将步骤(5)析出的羟乙基磺酸溶解后,加氢氧化钠溶液,调节pH值至中性,于95℃温度条件下蒸发结晶,得到羟乙基磺酸钠固体。(7) Neutralization of isethionic acid: after dissolving the isethionic acid precipitated in step (5), add sodium hydroxide solution to adjust the pH value to neutrality, and evaporate and crystallize at a temperature of 95 ℃ to obtain hydroxyethylsulfonic acid. Sodium ethylsulfonate solid.
在本发明中,步骤(1)中,搅拌时间为30min。In the present invention, in step (1), the stirring time is 30min.
在本发明中,步骤(2)中,搅拌时间为30min。In the present invention, in step (2), the stirring time is 30min.
在本发明中,步骤(3)中,在二级滤液中加入的乙醇为60~100mL。In the present invention, in step (3), the amount of ethanol added to the secondary filtrate is 60-100 mL.
在本发明中,步骤(3)中,于90℃温度条件下继续搅拌反应时间为30min。In the present invention, in step (3), the reaction time is 30min under the condition of 90°C temperature.
在本发明中,步骤(4)中,在油层中加入的水为30~50mL。In the present invention, in step (4), the water added to the oil layer is 30-50 mL.
在本发明中,步骤(4)中,于80℃温度条件下继续搅拌反应时间为1h。In the present invention, in step (4), the reaction time is 1h under the condition of 80°C temperature.
在本发明中,步骤(5)中,于95℃温度条件下蒸发结晶时间为1h。In the present invention, in step (5), the evaporative crystallization time is 1h under the temperature condition of 95°C.
在本发明中,步骤(6)中,于5℃温度条件下冷却结晶时间为2h。In the present invention, in step (6), the cooling crystallization time is 2h at a temperature of 5°C.
在本发明中,步骤(7)中,氢氧化钠溶液浓度为1mol/L。In the present invention, in step (7), the concentration of sodium hydroxide solution is 1 mol/L.
有益效果:Beneficial effects:
(1)本发明以牛磺酸结晶母液为原料,经沉淀、酸化、酯化、水解、蒸发结晶、冷却结晶等工艺,最终从牛磺酸结晶结晶母液中分离出有用成分牛磺酸和羟乙基磺酸钠,利用该方法不仅能够有效回收牛磺酸结晶母液中有用成分牛磺酸和羟乙基磺酸钠,而且能够显著减少牛磺酸生产废液排放可能带来的环境污染,具有生产成本低、回收率高,易于工业放大的优点;(1) The present invention uses taurine crystallization mother liquor as raw material, and finally separates useful components taurine and hydroxyl from the taurine crystallization mother liquor through processes such as precipitation, acidification, esterification, hydrolysis, evaporative crystallization, and cooling crystallization. Sodium ethyl sulfonate, using this method not only can effectively recover useful components taurine and sodium isethionate in the taurine crystallization mother liquor, but also can significantly reduce the environmental pollution that may be caused by the discharge of taurine production waste liquid, It has the advantages of low production cost, high recovery rate, and easy industrial scale-up;
(2)本发明利用乙醇酯化促使牛磺酸和羟乙基磺酸生成酯化产物,转移至油相,从而实现牛磺酸结晶母液中有用成分与杂质成分(乙二醇、聚乙二醇及硫酸钠)的高效分离,有效地解决常规方法难以分离的问题。(2) The present invention utilizes ethanol esterification to promote taurine and isethionic acid to generate an esterified product, which is transferred to the oil phase, thereby realizing useful components and impurity components (ethylene glycol, polyethylene The high-efficiency separation of alcohol and sodium sulfate) effectively solves the problem that conventional methods are difficult to separate.
附图说明Description of drawings
图1为本实施例的流程示意图。FIG. 1 is a schematic flowchart of this embodiment.
具体实施方式Detailed ways
为了使本发明实现的技术手段、创作特征、达成目的与功效易于明白清晰,下面结合具体实施例,进一步阐述本发明。In order to make the technical means, creative features, achievement goals and effects realized by the present invention easy to understand and clearly, the present invention will be further described below with reference to specific embodiments.
实施例1Example 1
一种分离牛磺酸结晶母液中有用成分的方法,具体步骤如下:A method for separating useful components in taurine crystallization mother liquor, the concrete steps are as follows:
(1)沉淀:于100 mL牛磺酸结晶母液中加入约3g氯化钡,搅拌30min,使硫酸钡充分析出,过滤分离硫酸钡,得一级滤液;(1) Precipitation: add about 3 g of barium chloride to 100 mL of taurine crystallization mother liquor, stir for 30 min to fully separate out barium sulfate, and filter and separate barium sulfate to obtain a primary filtrate;
(2)酸化:于一级滤液中加入30 mL浓盐酸,升温至80℃温度条件下搅拌30min,促使羟乙基磺酸钠转化为羟乙基磺酸,同时会有氯化钠析出,过滤分离氯化钠,得二级滤液;(2) Acidification: add 30 mL of concentrated hydrochloric acid to the primary filtrate, heat up to 80 °C and stir for 30 minutes to promote the conversion of sodium isethionate into isethionic acid, and at the same time, sodium chloride will be precipitated, filter Separate sodium chloride to obtain secondary filtrate;
(3)酯化:于二级滤液中加入60mL乙醇,于90℃温度条件下继续搅拌反应30min,溶液出现分层,水层含有乙醇、乙二醇、聚乙二醇及少量氯化钠和硫酸钠,分离水层后,油层含有酯化产物,包括牛磺酸酯和羟乙基磺酸酯;(3) Esterification: Add 60 mL of ethanol to the secondary filtrate, and continue to stir the reaction for 30 minutes at 90°C. The solution is layered, and the water layer contains ethanol, ethylene glycol, polyethylene glycol and a small amount of sodium chloride and Sodium sulfate, after separating the water layer, the oil layer contains esterification products, including taurine and isethionate;
(4)水解:于步骤(3)生成的油层中加入30 mL水,于80℃温度条件下继续搅拌反应1h得水解产物,通过加水搅拌促使牛磺酸酯和羟乙基磺酸酯分别转化为牛磺酸和羟乙基磺酸;(4) Hydrolysis: add 30 mL of water to the oil layer generated in step (3), continue to stir and react at 80°C for 1 h to obtain a hydrolyzed product, and promote the conversion of taurine and isethionate respectively by adding water and stirring For taurine and isethionic acid;
(5)蒸发结晶:对步骤(4)得到的水解产物进一步于95℃温度条件下蒸发结晶1h,析出羟乙基磺酸,过滤分离羟乙基磺酸后,得三级滤液;(5) Evaporative crystallization: the hydrolyzed product obtained in step (4) was further evaporated and crystallized at a temperature of 95 °C for 1 h to precipitate isethionic acid, and after filtration and separation of isethionic acid, a tertiary filtrate was obtained;
(6)冷却结晶:将步骤(5)得到的三级滤液于5℃温度条件下冷却结晶2h,直至牛磺酸充分析出,过滤分离固相产物,得到牛磺酸;(6) Crystallization by cooling: the tertiary filtrate obtained in step (5) was cooled and crystallized at a temperature of 5 °C for 2 hours until the taurine was fully separated, and the solid-phase product was separated by filtration to obtain taurine;
(7)羟乙基磺酸中和:将步骤(5)析出的羟乙基磺酸溶解后,加1mol/L氢氧化钠溶液,调节pH值至中性,于95℃温度条件下蒸发结晶,得到羟乙基磺酸钠固体。(7) Neutralization of isethionic acid: after dissolving the isethionic acid precipitated in step (5), add 1 mol/L sodium hydroxide solution, adjust the pH value to neutrality, and evaporate and crystallize at a temperature of 95 °C , to obtain sodium isethionate as a solid.
以100 mL牛磺酸结晶母液为原料,分离实验结果表明,牛磺酸纯度98%,收率62%;羟乙基磺酸钠纯度为95%,收率为55%。Using 100 mL of taurine crystallization mother liquor as raw material, the results of separation experiments showed that the purity of taurine was 98%, and the yield was 62%; the purity of sodium isethionate was 95%, and the yield was 55%.
实施例2Example 2
一种分离牛磺酸结晶母液中有用成分的方法,具体步骤如下:A method for separating useful components in taurine crystallization mother liquor, the concrete steps are as follows:
(1)沉淀:于100 mL牛磺酸结晶母液中加入约3g氯化钡,搅拌30min,使硫酸钡充分析出,过滤分离硫酸钡,得一级滤液;(1) Precipitation: add about 3 g of barium chloride to 100 mL of taurine crystallization mother liquor, stir for 30 min to fully separate out barium sulfate, and filter and separate barium sulfate to obtain a primary filtrate;
(2)酸化:于一级滤液中加入30 mL浓盐酸,升温至80℃温度条件下搅拌30min,促使羟乙基磺酸钠转化为羟乙基磺酸,同时会有氯化钠析出,过滤分离氯化钠,得二级滤液;(2) Acidification: add 30 mL of concentrated hydrochloric acid to the primary filtrate, heat up to 80 °C and stir for 30 minutes to promote the conversion of sodium isethionate into isethionic acid, and at the same time, sodium chloride will be precipitated, filter Separate sodium chloride to obtain secondary filtrate;
(3)酯化:于二级滤液中加入80mL乙醇,于90℃温度条件下继续搅拌反应30min,溶液出现分层,水层含有乙醇、乙二醇、聚乙二醇及少量氯化钠和硫酸钠,分离水层后,油层含有酯化产物,包括牛磺酸酯和羟乙基磺酸酯;(3) Esterification: Add 80 mL of ethanol to the secondary filtrate, and continue to stir the reaction for 30 min at 90°C. The solution is layered, and the aqueous layer contains ethanol, ethylene glycol, polyethylene glycol and a small amount of sodium chloride and Sodium sulfate, after separating the water layer, the oil layer contains esterification products, including taurine and isethionate;
(4)水解:于步骤(3)生成的油层中加入40 mL水,于80℃温度条件下继续搅拌反应1h得水解产物,通过加水搅拌促使牛磺酸酯和羟乙基磺酸酯分别转化为牛磺酸和羟乙基磺酸;(4) Hydrolysis: add 40 mL of water to the oil layer generated in step (3), continue to stir and react at 80 °C for 1 h to obtain a hydrolyzed product, and promote the conversion of taurine and isethionate respectively by adding water and stirring for taurine and isethionic acid;
(5)蒸发结晶:对步骤(4)得到的水解产物进一步于95℃温度条件下蒸发结晶1h,析出羟乙基磺酸,过滤分离羟乙基磺酸后,得三级滤液;(5) Evaporative crystallization: the hydrolyzed product obtained in step (4) was further evaporated and crystallized at a temperature of 95 °C for 1 h to precipitate isethionic acid, and after filtration and separation of isethionic acid, a tertiary filtrate was obtained;
(6)冷却结晶:将步骤(5)得到的三级滤液于5℃温度条件下冷却结晶2h,直至牛磺酸充分析出,过滤分离固相产物,得到牛磺酸;(6) Crystallization by cooling: the tertiary filtrate obtained in step (5) was cooled and crystallized at a temperature of 5 °C for 2 hours until the taurine was fully separated, and the solid-phase product was separated by filtration to obtain taurine;
(7)羟乙基磺酸中和:将步骤(5)析出的羟乙基磺酸溶解后,加1mol/L氢氧化钠溶液,调节pH值至中性,于95℃温度条件下蒸发结晶,得到羟乙基磺酸钠固体。(7) Neutralization of isethionic acid: after dissolving the isethionic acid precipitated in step (5), add 1 mol/L sodium hydroxide solution, adjust the pH value to neutrality, and evaporate and crystallize at a temperature of 95 °C , to obtain sodium isethionate as a solid.
以100 mL牛磺酸结晶母液为原料,分离实验结果表明,牛磺酸纯度98%,收率81%;羟乙基磺酸钠纯度为95%,收率为68%。Using 100 mL of taurine crystal mother liquor as raw material, the results of separation experiments showed that the purity of taurine was 98% and the yield was 81%; the purity of sodium isethionate was 95% and the yield was 68%.
实施例3Example 3
一种分离牛磺酸结晶母液中有用成分的方法,具体步骤如下:A method for separating useful components in taurine crystallization mother liquor, the concrete steps are as follows:
(1)沉淀:于100 mL牛磺酸结晶母液中加入约3g氯化钡,搅拌30min,使硫酸钡充分析出,过滤分离硫酸钡,得一级滤液;(1) Precipitation: add about 3 g of barium chloride to 100 mL of taurine crystallization mother liquor, stir for 30 min to fully separate out barium sulfate, and filter and separate barium sulfate to obtain a primary filtrate;
(2)酸化:于一级滤液中加入30 mL浓盐酸,升温至80℃温度条件下搅拌30min,促使羟乙基磺酸钠转化为羟乙基磺酸,同时会有氯化钠析出,过滤分离氯化钠,得二级滤液;(2) Acidification: add 30 mL of concentrated hydrochloric acid to the primary filtrate, heat up to 80 °C and stir for 30 minutes to promote the conversion of sodium isethionate into isethionic acid, and at the same time, sodium chloride will be precipitated, filter Separate sodium chloride to obtain secondary filtrate;
(3)酯化:于二级滤液中加入100mL乙醇,于90℃温度条件下继续搅拌反应30min,溶液出现分层,水层含有乙醇、乙二醇、聚乙二醇及少量氯化钠和硫酸钠,分离水层后,油层含有酯化产物,包括牛磺酸酯和羟乙基磺酸酯;(3) Esterification: Add 100 mL of ethanol to the secondary filtrate, and continue to stir the reaction for 30 minutes at 90°C. The solution is stratified, and the water layer contains ethanol, ethylene glycol, polyethylene glycol and a small amount of sodium chloride and Sodium sulfate, after separating the water layer, the oil layer contains esterification products, including taurine and isethionate;
(4)水解:于步骤(3)生成的油层中加入50 mL水,于80℃温度条件下继续搅拌反应1h得水解产物,通过加水搅拌促使牛磺酸酯和羟乙基磺酸酯分别转化为牛磺酸和羟乙基磺酸;(4) Hydrolysis: Add 50 mL of water to the oil layer generated in step (3), continue to stir and react at 80 °C for 1 h to obtain a hydrolyzed product, and promote the conversion of taurine and isethionate by adding water and stirring. for taurine and isethionic acid;
(5)蒸发结晶:对步骤(4)得到的水解产物进一步于95℃温度条件下蒸发结晶1h,析出羟乙基磺酸,过滤分离羟乙基磺酸后,得三级滤液;(5) Evaporative crystallization: the hydrolyzed product obtained in step (4) was further evaporated and crystallized at a temperature of 95 °C for 1 h to precipitate isethionic acid, and after filtration and separation of isethionic acid, a tertiary filtrate was obtained;
(6)冷却结晶:将步骤(5)得到的三级滤液于5℃温度条件下冷却结晶2h,直至牛磺酸充分析出,过滤分离固相产物,得到牛磺酸;(6) Crystallization by cooling: the tertiary filtrate obtained in step (5) was cooled and crystallized at a temperature of 5 °C for 2 hours until the taurine was fully separated, and the solid-phase product was separated by filtration to obtain taurine;
(7)羟乙基磺酸中和:将步骤(5)析出的羟乙基磺酸溶解后,加1mol/L氢氧化钠溶液,调节pH值至中性,于95℃温度条件下蒸发结晶,得到羟乙基磺酸钠固体。(7) Neutralization of isethionic acid: after dissolving the isethionic acid precipitated in step (5), add 1 mol/L sodium hydroxide solution, adjust the pH value to neutrality, and evaporate and crystallize at a temperature of 95 °C , to obtain sodium isethionate as a solid.
以100 mL牛磺酸结晶母液为原料,分离实验结果表明,牛磺酸纯度99%,收率90%;羟乙基磺酸钠纯度为97%,收率为82%。Using 100 mL of taurine crystal mother liquor as raw material, the results of separation experiments showed that the purity of taurine was 99% and the yield was 90%; the purity of sodium isethionate was 97% and the yield was 82%.
在上述实施例中,牛磺酸结晶母液为牛磺酸生产废液,其主要成分包括:牛磺酸、牛磺酸钠、羟乙基磺酸钠、乙二醇、聚乙二醇及硫酸钠。In the above embodiment, the taurine crystallization mother liquor is a taurine production waste liquid, and its main components include: taurine, sodium taurine, sodium isethionate, ethylene glycol, polyethylene glycol and sulfuric acid sodium.
通过对实施例1~实施例3制备的有用成分进行分离实验结果可知,实施例3 (按酯化步骤中加入100mL乙醇,水解步骤中加入50 mL水实施)分离效果最佳,此时牛磺酸纯度99%,收率90%;羟乙基磺酸钠纯度为97%,收率为82%,随酯化步骤中乙醇加入量增加,酯化产物增加,因此水解步骤中水的加入量也应相应增加,此时牛磺酸和羟乙基磺酸钠收率和纯度也会提高;但进一步增加乙醇和水用量,牛磺酸和羟乙基磺酸钠收率和纯度提高效果不明显,且会增加后续分离负荷和生产成本。From the results of the separation experiment of the useful components prepared in Examples 1 to 3, it can be seen that the separation effect of Example 3 (by adding 100 mL of ethanol in the esterification step and adding 50 mL of water in the hydrolysis step) is the best. At this time, taurine The acid purity is 99%, and the yield is 90%; the purity of sodium isethionate is 97%, and the yield is 82%. As the amount of ethanol added in the esterification step increases, the esterification product increases, so the amount of water added in the hydrolysis step It should also be increased accordingly. At this time, the yield and purity of taurine and sodium isethionate will also increase; but further increase the amount of ethanol and water, the yield and purity of taurine and sodium isethionate will not improve. Obviously, it will increase the subsequent separation load and production cost.
以上显示和描述了本发明的基本原理和主要特征和本发明的优点。本行业的技术人员应该了解,本发明不受上述实施例的限制,上述实施例和说明书中描述的只是说明本发明的原理,在不脱离本发明精神和范围的前提下,本发明还会有各种变化和改进,这些变化和改进都落入要求保护的本发明范围内。本发明要求保护范围由所附的权利要求书及其等效物界定。The basic principles and main features of the present invention and the advantages of the present invention have been shown and described above. It should be understood by those skilled in the art that the present invention is not limited by the above-mentioned embodiments. What is described in the above-mentioned embodiments and the description is only to illustrate the principle of the present invention. Without departing from the spirit and scope of the present invention, the present invention will also have Various changes and modifications fall within the scope of the claimed invention. The claimed scope of the present invention is defined by the appended claims and their equivalents.
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010080277.5A CN111233717B (en) | 2020-02-05 | 2020-02-05 | Method for separating useful components in taurine crystallization mother liquor |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010080277.5A CN111233717B (en) | 2020-02-05 | 2020-02-05 | Method for separating useful components in taurine crystallization mother liquor |
Publications (2)
Publication Number | Publication Date |
---|---|
CN111233717A CN111233717A (en) | 2020-06-05 |
CN111233717B true CN111233717B (en) | 2022-05-31 |
Family
ID=70871873
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010080277.5A Active CN111233717B (en) | 2020-02-05 | 2020-02-05 | Method for separating useful components in taurine crystallization mother liquor |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111233717B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114315657B (en) | 2021-12-24 | 2023-09-29 | 潜江永安药业股份有限公司 | Method for recycling taurine mother liquor |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103483228A (en) * | 2013-10-16 | 2014-01-01 | 吉林伊捷思化学有限公司 | Preparation method of sodium hydroxyethyl sulfonate fatty acid ester |
CN107056659A (en) * | 2017-06-16 | 2017-08-18 | 潜江永安药业股份有限公司 | A kind of method of the production taurine of circulation in high yield |
CN109020839A (en) * | 2018-10-29 | 2018-12-18 | 吴江 | A kind of ammonolysis ethylenehydrinsulfonic acid sodium prepares taurine utilization process |
CN109704508A (en) * | 2017-10-25 | 2019-05-03 | 于德志 | A kind of processing method of the liquid containing ammonium sulfate high-salt wastewater generated in taurine production technology |
CN110590613A (en) * | 2019-10-16 | 2019-12-20 | 潜江永安药业股份有限公司 | Method and production system for fully recycling taurine mother liquor |
CN110590614A (en) * | 2019-08-28 | 2019-12-20 | 王建峰 | Separation and purification process of taurine |
-
2020
- 2020-02-05 CN CN202010080277.5A patent/CN111233717B/en active Active
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103483228A (en) * | 2013-10-16 | 2014-01-01 | 吉林伊捷思化学有限公司 | Preparation method of sodium hydroxyethyl sulfonate fatty acid ester |
CN107056659A (en) * | 2017-06-16 | 2017-08-18 | 潜江永安药业股份有限公司 | A kind of method of the production taurine of circulation in high yield |
CN109704508A (en) * | 2017-10-25 | 2019-05-03 | 于德志 | A kind of processing method of the liquid containing ammonium sulfate high-salt wastewater generated in taurine production technology |
CN109020839A (en) * | 2018-10-29 | 2018-12-18 | 吴江 | A kind of ammonolysis ethylenehydrinsulfonic acid sodium prepares taurine utilization process |
CN110590614A (en) * | 2019-08-28 | 2019-12-20 | 王建峰 | Separation and purification process of taurine |
CN110590613A (en) * | 2019-10-16 | 2019-12-20 | 潜江永安药业股份有限公司 | Method and production system for fully recycling taurine mother liquor |
Non-Patent Citations (5)
Title |
---|
牛磺酸母液分离过程中牛磺酸流失的原因与解决办法;赵成茂等;《辽宁化工》;20040228(第02期);第63-65页 * |
牛磺酸氨解反应工艺研究;刘福明等;《山东化工》;20150308(第05期);第27-29页 * |
牛磺酸生产中粗品母液的电渗析分离工艺;任举等;《安徽化工》;20160815(第04期);第52-54页 * |
牛磺酸精结晶方法的研究;陆剑平等;《天津化工》;20111130(第06期);第30-32页 * |
饱和水溶液的膜蒸馏――从废液回收牛磺酸的实验研究;吴庸烈等;《水处理技术》;19910815(第04期);第226-229页 * |
Also Published As
Publication number | Publication date |
---|---|
CN111233717A (en) | 2020-06-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN108862335B (en) | Method for preparing lithium carbonate from lithium phosphate | |
JPWO2022009004A5 (en) | ||
JP2001514900A (en) | Method for producing and purifying succinic acid | |
JP6926010B2 (en) | Method for producing lithium hydroxide | |
CN111233717B (en) | Method for separating useful components in taurine crystallization mother liquor | |
KR100399509B1 (en) | Process for purifying valine | |
CN109369712B (en) | A method of with calcium salt separating-purifying glufosinate-ammonium | |
CN104119243A (en) | Iminodiacetic acid energy saving cleaning production method | |
CN109651211A (en) | A method of preparing 2,3- sodium dimercaptopropane sulfonate | |
CN107640778B (en) | A method of the low cost recycling sodium sulphate from leaded desulfurization waste liquor | |
CN1202013C (en) | Process for united producing barium hydroxide and manganese sulfate | |
CN109574893A (en) | A kind of method of sodium thiocarbonate synthesis mercaptoethylamine hydrochloride | |
CN114715931A (en) | Method for preparing high-purity gallium nitrate from sponge gallium | |
CN113461508B (en) | Preparation method of alpha-ketophenylalanine calcium | |
BR112019013541A2 (en) | PROCESS FOR THE PREPARATION OF POTASSIC FERTILIZER | |
SU1126208A3 (en) | Process for preparing alkylthiobenzimidazoles | |
US11858883B2 (en) | Method for recycling taurine mother liquor | |
CN112409196A (en) | Preparation process of aminomethylbenzoic acid based on Delbin reaction | |
CN111333087A (en) | Preparation method of lithium hydroxide | |
CN115872883B (en) | A method for preparing high-purity sarcosine | |
CN112661719B (en) | Clean preparation process of aminothiazoly loximate | |
CN113735727B (en) | Preparation method of raceme ketoisoleucine calcium and intermediate thereof | |
CN118754161A (en) | A method for refining lithium hydroxide | |
CN110818602A (en) | Method for preparing high-purity cysteamine hydrochloride | |
CN119059535A (en) | Zero-emission recycling method and device for high-salt wastewater with sodium chloride as main component |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |